Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Looking to boost your income quickly? Explore effective ways to make fast money in just 5 days and take control of your finances.
18,113 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A veteran program manager at a leading mortgage tech firm is accelerating digital lending by turning strategic plans ...
A surprising Nasdaq pullback compounds the pressure on AI stock bets as traders brace for a week of earnings, IPOs, a...
Two travel giants—Vail Resorts and Viking Holdings—represent different bets on leisure demand. This analysis compares...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
In 2026, two healthcare real estate REITs stand out for income-focused investors: Community Healthcare Trust and Sabr...
A Bitcoin-native DeFi project is winding down amid weak demand, underscoring a broader hurdle for BTC yield ecosystem...
BTCC unveils a sweeping zero-fee program that covers funding, spot trades, and futures, signaling a major shift in cr...
A temporary extra deduction for seniors entered 2026, changing how Social Security benefits are taxed and prompting n...
Tilray Brands has evolved from a pure-play cannabis company into a diversified player. This guide breaks down what to...
When a company’s CFO sells a sizable block of stock, investors sit up and take notice. This article breaks down what ...